Ozempic Face in Plastic Surgery (ASJ Open Forum 2025)

Board-certified Beverly Hills plastic surgeon Dr. Daniel Gould, MD, PhD co-authored a peer-reviewed article in Aesthetic Surgery Journal Open Forum examining facial volume loss and aging changes associated with rapid weight loss from GLP-1 medications such as semaglutide.

The study discusses how significant weight loss can lead to facial hollowing, skin laxity, and structural volume loss, and reviews surgical and nonsurgical treatment approaches used in facial rejuvenation following major weight reduction.